bucladesine has been researched along with Hepatitis, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kitamura, K; Matsumoto, M; Oka, K; Oku, A; Sugiura, M; Taguchi, I | 1 |
1 other study(ies) available for bucladesine and Hepatitis, Animal
Article | Year |
---|---|
Protection by a cyclic AMP-specific phosphodiesterase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitis.
Topics: Animals; Bucladesine; Hepatitis, Animal; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Phosphodiesterase Inhibitors; Propionibacterium acnes; Pyrrolidinones; Rolipram; Tumor Necrosis Factor-alpha | 1999 |